Key Highlights

  • Profusa shares are up 97.57% in pre-market trading to $8.95, nearly doubling after closing up 25.83% at $4.53 on Thursday.
  • No specific news catalyst explaining today's move has been identified in available source material as of this writing.
  • The move comes days after Profusa completed a 1-for-4 reverse stock split, which took effect August 17, 2026, reducing shares outstanding from approximately 2.42 million to approximately 605,726.
  • With a market Capitalization of roughly $5 million even after today's surge, Profusa remains an extremely thinly traded micro-cap stock, where large percentage swings can occur on relatively low trading volume.

What We Know

Profusa (NASDAQ:PFSA) shares are surging in pre-market trading today, nearly doubling in value, though no specific news catalyst for the move has been identified in available source material as of this writing. Profusa is a Berkeley, California-based commercial-stage digital health company developing tissue-integrated biosensors designed to continuously monitor an individual's biochemistry, with its lead offering, the Lumee Oxygen Platform, providing real-time tissue oxygen monitoring for conditions such as peripheral artery disease and chronic non-healing wounds.

The most recent identifiable corporate development is a 1-for-4 reverse stock split, which the company announced on August 13 and which took effect at the start of trading on August 17, 2026. Under the split, every four shares of common stock were consolidated into one share, reducing total shares outstanding from approximately 2,422,906 to approximately 605,726, with the stock continuing to trade under the same ticker symbol but a new CUSIP number. Reverse splits are a mechanical adjustment that increases per-share price without changing a company's underlying market value, and Thursday's close of $4.53 already reflected the post-split price.

A Thinly Traded Micro-Cap Move

Today's pre-market surge represents a genuine additional gain on top of the already-completed reverse split, not simply a split-adjustment artifact, based on the reported share and price figures. However, with a market capitalization of only around $5 million even after the move, Profusa remains an extremely thinly traded micro-cap stock. In such names, large percentage price swings can occur on relatively small dollar volumes of trading, and moves of this magnitude without an identifiable news catalyst Warrant particular caution.

Conclusion

Profusa shares are sharply higher in pre-market trading today, though the size of the move and the absence of an identified catalyst make it difficult to point to a specific driver behind the surge. Given the stock's extremely small market capitalization and recent reverse split, investors should treat today's price action with caution until further information or an official company statement clarifies what, if anything, is driving the move.